Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorArriola, E.
dc.contributor.authorCampelo, M. R. Garcia
dc.contributor.authorTain, M. P. Diz
dc.contributor.authorBlanco, M. C. Marti
dc.contributor.authorVega, A. L. Moreno
dc.contributor.authorLeon-Mateos, L.
dc.contributor.authorCalderon, V. Gutierrez
dc.contributor.authorHernandez, A. Sanchez
dc.contributor.authorRodriguez, J. M. Oramas
dc.contributor.authorMajem, M.
dc.contributor.authorDe la Rosa, C. Aguado
dc.contributor.authorCabellos, R. Alvarez
dc.contributor.authorCiriquian, J. L. Marti
dc.contributor.authorAmezcua, V.
dc.contributor.authorPerez, J. L. Firvida
dc.contributor.authorMellen, A. Callejo
dc.contributor.authorBaez, L.
dc.contributor.authorIsla, D.
dc.contributor.authoraffiliation[Paz-Ares, L.] Univ Hosp 12 Octubre, Med Oncol Dept, Edificio Maternidad, Madrid, Spain
dc.contributor.authoraffiliation[Arriola, E.] Hosp Mar, Dept Med Oncol, Parc Salut Mar, Barcelona, Spain
dc.contributor.authoraffiliation[Campelo, M. R. Garcia] Complexo Hosp Univ A Coruna, Dept Med Oncol, La Coruna, Spain
dc.contributor.authoraffiliation[Tain, M. P. Diz] Complejo Asistencial Univ Leon, Dept Med Oncol, Leon, Spain
dc.contributor.authoraffiliation[Blanco, M. C. Marti] Hosp Univ St Joan Reus, Med Oncol, Reus, Spain
dc.contributor.authoraffiliation[Vega, A. L. Moreno] Hosp Univ Reina Sofia, Med Oncol, Cordoba, Spain
dc.contributor.authoraffiliation[Leon-Mateos, L.] Complexo Hosp Univ Santiago de Compostela, Med Oncol, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Calderon, V. Gutierrez] Hosp Reg Univ Malaga, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Hernandez, A. Sanchez] Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Spain
dc.contributor.authoraffiliation[Rodriguez, J. M. Oramas] Hosp Univ Canarias, Med Oncol, San Crisatobal De La, Spain
dc.contributor.authoraffiliation[Majem, M.] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[De la Rosa, C. Aguado] Hosp Clin San Carlos, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Cabellos, R. Alvarez] Hosp Virgen Salud, Oncol Med, Toledo, Spain
dc.contributor.authoraffiliation[Ciriquian, J. L. Marti] Hosp Gen Univ Alicante, Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Amezcua, V.] Complejo Hosp Univ Granada, Med Oncol, Granada, Spain
dc.contributor.authoraffiliation[Perez, J. L. Firvida] Complexo Hosp Univ Ourense, Med Oncol, Orense, Spain
dc.contributor.authoraffiliation[Mellen, A. Callejo] AstraZeneca Farmaceut Spain SA, Dept Med, Madrid, Spain
dc.contributor.authoraffiliation[Baez, L.] AstraZeneca Farmaceut Spain SA, Dept Med, Madrid, Spain
dc.contributor.authoraffiliation[Isla, D.] Hosp Clin Lozano Blesa, Med Oncol, Zaragoza, Spain
dc.contributor.funderAstraZeneca
dc.date.accessioned2025-01-07T13:50:17Z
dc.date.available2025-01-07T13:50:17Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.251
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.251
dc.identifier.urihttps://hdl.handle.net/10668/25896
dc.identifier.wosID700527703212
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.numberS1171-S1172
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleDurvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
SAS - Hospital Universitario San Cecilio
SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía